We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
Cap. Flow
-$5.59B
Cap. Flow %
-19.76%
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$97.8M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$95.6M
3
LNG icon
Cheniere Energy
LNG
+$94.4M
4
V icon
Visa
V
+$92.5M
5
AZN icon
AstraZeneca
AZN
+$88.2M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Healthcare 17.34%
3 Financials 13.09%
4 Industrials 10.79%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
76
Lantheus
LNTH
$6.68B
$94.1M 0.33%
1,425,140
+129,488
+10% +$8.16M
HLT icon
77
Hilton Worldwide
HLT
$73.4B
$94M 0.33%
843,497
-97,159
-10% -$13.4M
KKR icon
78
KKR & Co
KKR
$92.2B
$93.2M 0.33%
2,014,211
-493,327
-20% -$25.9M
TGT icon
79
Target
TGT
$65.5B
$92.5M 0.33%
654,972
+118,290
+22% +$22.7M
JPM icon
80
JPMorgan Chase
JPM
$950B
$90.9M 0.32%
807,142
-567,000
-41% -$70.2M
BPOP icon
81
Popular Inc
BPOP
$11.1B
$90.3M 0.32%
1,173,167
+271,579
+30% +$21.6M
BAH icon
82
Booz Allen Hamilton
BAH
$8.78B
$90.1M 0.32%
996,930
+96,690
+11% +$8.25M
HD icon
83
Home Depot
HD
$343B
$89.6M 0.32%
326,586
+860
+0.3% +$254K
AZN icon
84
AstraZeneca
AZN
$267B
$88.9M 0.31%
+672,542
New +$88.2M
LMT icon
85
Lockheed Martin
LMT
$134B
$88.4M 0.31%
205,638
-23,939
-10% -$10.5M
AMD icon
86
Advanced Micro Devices
AMD
$741B
$88.1M 0.31%
1,152,420
-326,910
-22% -$30.6M
V icon
87
Visa
V
$697B
$88.1M 0.31%
+447,407
New +$92.5M
PXD
88
DELISTED
Pioneer Natural Resource Co.
PXD
$86.2M 0.3%
386,563
-188,293
-33% -$47.8M
DOV icon
89
Dover
DOV
$27.4B
$85.9M 0.3%
708,400
-366,874
-34% -$49.6M
TMO icon
90
Thermo Fisher Scientific
TMO
$214B
$84.8M 0.3%
156,069
-71,714
-31% -$39.5M
XOM icon
91
ExxonMobil
XOM
$634B
$84.2M 0.3%
982,723
-180,400
-16% -$16.3M
AMT icon
92
American Tower
AMT
$79.9B
$83M 0.29%
324,600
-300
-0.1% -$75.3K
SRLN icon
93
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$82.8M 0.29%
1,988,680
-970,524
-33% -$42.2M
CZR icon
94
Caesars Entertainment
CZR
$6.1B
$82.7M 0.29%
2,160,365
+406,462
+23% +$22.6M
EEFT icon
95
Euronet Worldwide
EEFT
$3.15B
$81.2M 0.29%
806,787
-53,520
-6% -$6.34M
MAS icon
96
Masco
MAS
$16.5B
$77.6M 0.27%
1,533,241
-111,455
-7% -$5.89M
DDOG icon
97
Datadog
DDOG
$89.3B
$77.5M 0.27%
813,713
+9,770
+1% +$1.07M
AMH icon
98
American Homes 4 Rent
AMH
$12.2B
$77.2M 0.27%
+2,177,941
New +$82.4M
LFUS icon
99
Littelfuse
LFUS
$9.91B
$76.9M 0.27%
302,682
-55,252
-15% -$13.9M
UL icon
100
Unilever
UL
$144B
$76.6M 0.27%
+1,485,932
New +$75.7M

Similar funds

Lord, Abbett & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.

  • Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
  • Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
  • Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
  • Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
  • Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
  • Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
  • Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.